Joseph E. Aslan, PhD

Associate Professor
Oregon Health & Science University

Joseph Aslan, Ph.D. is an Assistant Professor in the Knight Cardiovascular Institute at Oregon Health & Science University. Dr. Aslan's research focuses on molecular and cellular mechanisms of platelet function. Dr. Aslan is a Co-Chair of the ISTH Platelet Physiology SSC. Dr. Aslan is supported by research grants from the National Institutes of Health.

Presentation(s):

• LB 01.5 - Antiplatelet effects of inhibiting coagulation factor XI in a non-human primate model of atherosclerosis

  Sunday, July 10, 2022
  3:45 PM – 4:00 PM

• SSC 09.04 - Preanalytical Variables in Platelet Preparations for Proteomics Studies: New Project

  Sunday, July 10, 2022
  4:50 PM – 5:00 PM

• OC 35.5 - Quantitative Phosphoproteomics And Causal Analysis Reveal Distinct And Combinatorial Signaling Mechanisms In Protease-activated Receptor PAR1 And PAR4 Platelet Activation Programs

  Monday, July 11, 2022
  11:45 AM – 12:00 PM

• PB0845 - P2Y receptor antagonists and tyrosine kinase inhibitors reduce oxLDL-mediated procoagulant platelet activity

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0882 - Rab GTPase Protein localization, regulation and function in platelets

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0885 - Pregnancy-specific glycoprotein 9 potentiates platelet function mediated by immunoreceptor tyrosine-based activation motif pathways

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• OC 58.4 - Ibrutinib inhibits BMX-dependent endothelial VCAM-1 expression in vitro and pro-atherosclerotic endothelial activation and platelet adhesion in vivo

  Tuesday, July 12, 2022
  11:30 AM – 11:45 AM